Alkem Laboratories Limited (NSE:ALKEM)
5,314.50
-183.50 (-3.34%)
Jun 1, 2026, 3:30 PM IST
Alkem Laboratories Revenue
In the fiscal year ending March 31, 2026, Alkem Laboratories had annual revenue of 147.12B INR with 13.48% growth. Alkem Laboratories had revenue of 36.03B in the quarter ending March 31, 2026, with 14.62% growth.
Revenue
147.12B
Revenue Growth
+13.48%
P/S Ratio
4.47
Revenue / Employee
7.83M
Employees
18,785
Market Cap
657.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 147.12B | 17.48B | 13.48% |
| Mar 31, 2025 | 129.65B | 2.97B | 2.34% |
| Mar 31, 2024 | 126.68B | 10.68B | 9.21% |
| Mar 31, 2023 | 115.99B | 9.65B | 9.08% |
| Mar 31, 2022 | 106.34B | 17.69B | 19.96% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 336.53B |
| Cipla | 277.12B |
| Zydus Lifesciences | 271.48B |
| Glenmark Pharmaceuticals | 174.43B |
| Mankind Pharma | 142.78B |
| Ipca Laboratories | 98.21B |
| Emcure Pharmaceuticals | 92.04B |
| Laurus Labs | 68.13B |
Alkem Laboratories News
- 3 days ago - Alkem Laboratories shares rally over 6% after Q4 results; Revenue and EBITDA growth support sentiment - Business Upturn
- 3 days ago - Ashok Leyland, Wipro, Alkem Labs, Finolex Cables, Delta Corp, BDL, Zydus Life, HBL Engineering, Apar Industries, Indostar shares in focus today, May 29 - Business Upturn
- 3 days ago - Stocks to watch today on brokerages: Bharat Dynamics, ONGC, Siemens, Ashok Leyland in focus on May 29 - Business Upturn
- 4 days ago - Alkem Laboratories Transcript: Q4 25/26 - Transcripts
- 4 days ago - Alkem Laboratories Quarterly report: Q4 2026 - Filings
- 4 days ago - Alkem Laboratories Slides: Q4 2026 - Filings
- 4 days ago - Alkem Laboratories announces Rs 10 per share final dividend for FY26 - Business Upturn
- 5 days ago - Earnings To Watch: Alkem Laboratories Ltd (NSE:ALKEM) Reports Q4 2026 Result - GuruFocus